Search results
Results from the WOW.Com Content Network
The Trifecta (TM) Valve. (Photo: St. Jude Medical, Inc.) Conducted at 31 medical centers in the U.S., Canada and Europe, the study followed 1,014 eligible patients implanted with the Trifecta ...
An artificial heart valve is a one-way valve implanted into a person's heart to replace a heart valve that is not functioning properly (valvular heart disease). Artificial heart valves can be separated into three broad classes: mechanical heart valves, bioprosthetic tissue valves and engineered tissue valves.
St. Jude Medical was founded in 1976 to further develop bi-leaflet artificial heart valves, which were originally created in 1972 at the University of Minnesota. [4] [5] St. Jude Medical's bi-leaflet valve was developed in large part by Dr. Demetre Nicoloff of the University of Minnesota and St. Jude Medical employee Don Hanson.
For premium support please call: 800-290-4726 more ways to reach us
[3] In 1976, he founded St. Jude Medical where his team engineered the first bileaflet mechanical heart valve, which reduced the frequency of blood clots in patients. It still dominates the mechanical valve replacement market. [4] [5] In 1982, Villafana founded GV Medical, which developed a device to open blood vessels open. [6]
St. Jude Medical Announces First Transapical Implant of Portico Transcatheter Aortic Heart Valve New surgical approach represents continued expansion of company's less invasive heart valve program ...
In 2022, St. Jude Children's Research Hospital was named the second best children's cancer hospital in the U.S by U.S. News & World Report. [35] Peter C. Doherty, Ph.D., of St. Jude Children's Research Hospital was co-recipient of the 1996 Nobel Prize in Physiology or Medicine for work related to how the immune system kills virus-infected cells ...
St. Jude Medical Announces European Approval of the Portico Transcatheter Aortic Heart Valve ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYS: STJ) , a global medical device company ...